Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Perhaps the greatest piece of investment wisdom ever...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(64)
•••
Comment by TheTruth1234on Dec 07, 2023 12:28pm
149 Views
Post# 35773246

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Perhaps the greatest piece of investment wisdom ever...

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Perhaps the greatest piece of investment wisdom ever...
InitiumMMXXIII wrote: If nobody paid any attention to my posts, how come I got almost 7000 thumbs up, almost exclusively on this forum? (jdstox 2146 + JDavenport 2401+ Boomskid 2261 = 6808)

The numbers don't lie.

On the other hand, you, TT, do lie.


The numbers don't lie.


LMFAO!!!!!


Johnny boy, you just dont get it.  People here USED you for information. 

You were a puppet.   They fed your ALREADY INFLATED EGO in hopes to get more info out of you about Bioasis. 


That is it!!  


Notice your phone doesn't ring anymore Johnny boy?

Notice you dont get any more text messages anymore Johnny boy?

Notice you dont get the "thumbs up" or the reads anymore Johnny boy?


Investors here now know the truth about you.

You are a joke.  Pure entertainment. 


You are a blowhard. 



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities